Status:
COMPLETED
Effect of Platelet Rich Plasma and Keratinocyte Suspensions on Wound Healing
Lead Sponsor:
Centre Hospitalier Universitaire Vaudois
Conditions:
Skin Graft
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
Brief Summary
This prospective randomized trial evaluated the impact of autologous keratinocytes suspended in platelet concentrates on healing skin graft donor site wounds. It was hypothesized that the treatment wo...
Eligibility Criteria
Inclusion
- Skin graft donor sites total surface \< 15% BSA
- Skin graft donor site size: 0.2mm deep, 30 to 40 cm2 surface area
Exclusion
- Patients treated with immunosuppressors
- Patients treated with corticoids
- Patients suffering from terminal renal insufficiency
- Patients suffering from severe peripheral arteriopathy
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00856934
Start Date
June 1 2005
Last Update
March 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalier Universitaire Vaudois
Lausanne, Canton of Vaud, Switzerland, 1011